Cargando…
Effects of hyperinsulinemia on acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor via the PI3K/AKT pathway in non-small cell lung cancer cells in vitro
Patients with lung cancer harboring activating epidermal growth factor (EGFR) mutations and pre-existing diabetes have been demonstrated to exhibit poor responses to first-line EGFR-tyrosine kinase inhibitor (TKI) therapy. Strategies for the management of acquired resistance to EGFR-TKIs in patients...
Autores principales: | Chiu, Hsin-Yi, Chiang, Chi-Ming, Yeh, Szu-Peng, Jong, De-Shien, Wu, Leang-Shin, Liu, Hung-Chang, Chiu, Chih-Hsien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491043/ https://www.ncbi.nlm.nih.gov/pubmed/32963612 http://dx.doi.org/10.3892/ol.2020.12069 |
Ejemplares similares
-
Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease
por: Wu, Yi-Ying, et al.
Publicado: (2019) -
Neuroendocrine Differentiation in Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
por: Chang, Youjin, et al.
Publicado: (2013) -
Molecular Mechanism of Isocupressic Acid Supresses MA-10 Cell Steroidogenesis
por: Tsui, Kuan-Hao, et al.
Publicado: (2012) -
Insulin Resistance Induced by Hyperinsulinemia Coincides with a Persistent Alteration at the Insulin Receptor Tyrosine Kinase Domain
por: Catalano, Karyn J., et al.
Publicado: (2014) -
First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer
por: Huang, Allen Chung-Cheng, et al.
Publicado: (2021)